New breast imaging BSGI effective in detection of breast cancers

New breast imaging technology – breast specific gamma imaging – BSGI targets hard-to-detect cancers – Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Some breast cancers may regress naturally

Some breast cancers detected by repeated mammographic screening would not persist to be detectable by a single mammogram at the end of 6 years, and this raises the possibility that the natural course of some screen-detected invasive breast cancers is to spontaneously regress. – Breast cancer rates increased significantly in four Norwegian counties after women there began undergoing mammography every two years, according to a report in the November 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Laura Bush’s partnership for breast cancer awareness in Panama

First Lady Laura Bush’s Partnership for Breast Cancer Awareness and Research extends to Panama. M. D. Anderson Cancer Center, US Department of State, Susan G. Komen for the Cure to advance the fight against breast cancer. – The University of Texas M. D. Anderson Cancer Center marked the beginning of a collaborative effort to eradicate breast cancer in Panama through the Partnership for Breast Cancer Awareness and Research of the Americas today at an event with Laura Bush, the First Lady of the United States, and Vivian Fern?ndez de Torrijos, the First Lady of Panama.

Psychotherapy improves survival for breast cancer patients

Psychological interventions associated with breast cancer survival; Psychological intervention improves survival for breast cancer patients. – A new study finds that breast cancer patients who participate in intervention sessions focusing on improving mood, coping effectively, and altering health behaviors live longer than patients who do not receive such psychological support.

Calcium, vitamin D may not reduce breast cancer risk

Taking calcium and vitamin D supplements does not lower a woman?s risk of breast cancer, according to a randomized controlled trial. – Taking calcium and vitamin D supplements does not reduce breast cancer incidence in postmenopausal women, according to data from a randomized, doubled-blind, placebo-controlled trial published online November 11 in the Journal of the National Cancer Institute.

Vitamin B and Folic acid do not appear to affect cancer risk

Combined folic acid, vitamin B6, and vitamin B12 treatment had no significant effect on overall risk of total invasive cancer or breast cancer among women during the folic acid fortification era. – A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA.

Exercise protects against breast cancer

Vigorous activity protects against breast cancer, women 30% less likely to develop breast cancer. – Normal-weight women who carry out lots of vigorous exercise are approximately 30% less likely to develop breast cancer than those who don’t exercise vigorously.

Breast stem cell fate is regulated by notch

Breast stem cell fate is regulated by notch. Errant expression leads to uncontrolled breast ductal cell growth. – A normal developmental protein that sometimes goes awry has been implicated in breast cancer. This discovery indicates the mechanism by which inappropriate expression of the Notch pathway may contribute to breast cancer.

Anti inflammatory drugs linked with reduced breast cancer risk

Largest review of its kind associates anti-inflammatory drugs with reduced breast cancer risk – Analysis of data from 38 studies that enrolled more than 2.7 million women ? the largest of its kind ? by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users.

$19 Million to M. D. Anderson for breast cancer research

M. D. Anderson awarded nearly $19 million by Susan G. Komen for the Cure; Grants will Fund 11 Translational Breast Cancer Research Studies. – The University of Texas M. D. Anderson Cancer Center has received nearly $19 million in grants from Susan G. Komen for the Cure? as part of that organization’s new initiative to fast-track promising research to benefit breast cancer patients.

Health Newstrack